Live Breaking News & Updates on ஆற்றல் படிப்பு|Page 3

Stay updated with breaking news from ஆற்றல் படிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Choose wisely': Greta Thunberg warns House lawmakers on their legacies, urges end to fossil fuel subsidies


Choose wisely : Greta Thunberg warns House lawmakers on their legacies, urges end to fossil fuel subsidies
Jeanine Santucci, USA TODAY
Replay Video
UP NEXT
WASHINGTON  Teen climate activist Greta Thunberg called tax breaks for the fossil fuel industry a disgrace in testimony to Congress at an Earth Day hearing on subsidies. 
The 18-year-old activist from Sweden told the House Oversight Committee in the hearing on The Role of Fossil Fuel Subsidies in Preventing Action on the Climate Crisis that history would hold them accountable if they fail to take action to end fossil fuel subsidies, a cause taken up by the progressive wing of the Democratic Party. ....

United States , United Kingdom , Ralph Norman , Tara Houska , Greta Thunberg , Joe Biden , Ro Khanna , House Oversight Committee , Democratic Party , Energy Study Institute , Earth Day , Fossil Fuel Subsidies , Preventing Action , Energy Study , House Oversight , President Joe Biden , President Biden , Native American , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ரால்ப் நார்மன் , தாரா ஹவுஸ்கா , ஓஹோ பிடென் , றோ கண்ணா , வீடு ஓவர்‌ஸைட் குழு , ஜனநாயக கட்சி ,

Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia Gravis (gMG) at the 2021 American Academy of Neurology Virtual Meeting


Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia Gravis (gMG) at the 2021 American Academy of Neurology Virtual Meeting
Full results from the Vivacity-MG study to be presented for the first time during an oral presentation
News provided by
Share this article
Share this article
TITUSVILLE, N.J., April 16, 2021 /PRNewswire/  The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the full results from the Phase 2 Vivacity-MG study of the investigational compound, nipocalimab (M281), in generalized myasthenia gravis (gMG)–a chronic, autoimmune neuromuscular disease. The data will be featured as part of an oral presentation at the American Academy of Neurology (AAN) Virtual Meeting taking place April 17-22, 2021. ....

United States , Jennifer Mcintyre , Bill Martin , Chris Delorefice , Luc Truyen , None Of The Janssen Pharmaceutical Companies , Energy Study , Momenta Pharmaceuticals Inc , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Exchange Commission , Us Food Drug Administration , Companies Of Johnson , American Academy Of Neurology , Lancet Regional Health , American Academy , Virtual Meeting , Autoimmune Neurology , Clinical Trials , Neurologic Disorders , Myasthenia Gravis Activities , Daily Living , Global Head , External Affairs , Janssen Research ,